Overview

Exploratory Study of OMS302 Injection in Subjects Undergoing Unilateral Cataract Extraction by Phacoemulsification.

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
This is an exploratory study to determine the safety and clinical benefit of OMS302 Injection in subjects undergoing Cataract Extraction with Lens Replacement (CELR) using a coaxial phacoemulsification process.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Omeros Corporation
Treatments:
Mydriatics
Pharmaceutical Solutions